View on Pubmed.gov 15975993 | View on doi.org 10.1093/eurhear...
Inflammation in the genesis and perpetuation of atrial fibrillation.
- Department of Cardiology 2142, The Heart Center, University Hospital of Copenhagen, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark. engelmann@dadlnet.dk
Abstract
The prevalence and persistence of atrial fibrillation (AF) and the relative inefficacy of the currently available pharmacotherapy requires development of new treatment strategies. Recent findings have suggested a mechanistic link between inflammatory processes and the development of AF. Epidemiological studies have shown an association between C-reactive protein and both the presence of AF and the risk of developing future AF. In case-control studies, C-reactive protein is significantly elevated in AF patients and is associated with successful cardioversion. Moreover, C-reactive protein elevation is more pronounced in patients with persistent AF than in those with paroxysmal AF. Furthermore, treatment with glucocorticoids, statins, angiotensin converting enzyme inhibitors, and angiotensin II receptor blockers seems to reduce recurrence of AF. Part of this anti-arrhythmic effect may be through anti-inflammatory activity. This article reviews what is known about inflammation in genesis and perpetuation of AF, the putative underlying mechanisms, and possible therapeutic implications for the inhibition of inflammation as an evolving treatment modality for AF.
References
Cited by 401 citations (total)
Journal Article
Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation.
Electronic publication date June 6, 2009
Rafik R Anis
Atrial fibrillation (AF) is the most common clinical arrhythmia, and is difficult to treat. Current treatment strategies are far from...
Journal Article Research Support, Non-U.S. Gov't
Single nucleotide polymorphisms in inflammatory genes and the risk of early onset of lone atrial fibrillation.
Electronic publication date January 28, 2011
Kristoffer M A Henningsen [...] Jesper Hastrup Svendsen et al.
BACKGROUND
Systemic low-grade inflammation is a prognostic risk factor of atrial fibrillation (AF).
OBJECTIVE
We hypothesized that genetic polymorphisms, which determine the rate...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Substances
- •
- •